Legal & General Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
310,291
+13,462
| +5% | +$45.8K | ﹤0.01% | 2222 |
|
|
2025
Q1 | $1.19M | Sell |
296,829
-16,208
| -5% | -$65K | ﹤0.01% | 2121 |
|
|
2024
Q4 | $2.03M | Buy |
313,037
+20,699
| +7% | +$134K | ﹤0.01% | 1975 |
|
|
2024
Q3 | $1.62M | Buy |
292,338
+12,863
| +5% | +$71.3K | ﹤0.01% | 2057 |
|
|
2024
Q2 | $1.56M | Sell |
279,475
-8,191
| -3% | -$45.7K | ﹤0.01% | 2054 |
|
|
2024
Q1 | $1.93M | Sell |
287,666
-1,100
| -0.4% | -$7.38K | ﹤0.01% | 1958 |
|
|
2023
Q4 | $2.63M | Buy |
288,766
+9,655
| +3% | +$88.1K | ﹤0.01% | 1809 |
|
|
2023
Q3 | $1.54M | Buy |
279,111
+47,532
| +21% | +$262K | ﹤0.01% | 2010 |
|
|
2023
Q2 | $1.98M | Buy |
231,579
+194,270
| +521% | +$1.66M | ﹤0.01% | 1936 |
|
|
2023
Q1 | $343K | Buy |
37,309
+1,429
| +4% | +$13.1K | ﹤0.01% | 2423 |
|
|
2022
Q4 | $366K | Buy |
35,880
+425
| +1% | +$4.34K | ﹤0.01% | 2415 |
|
|
2022
Q3 | $522K | Sell |
35,455
-4,199
| -11% | -$61.8K | ﹤0.01% | 2333 |
|
|
2022
Q2 | $425K | Buy |
39,654
+29,802
| +302% | +$319K | ﹤0.01% | 2381 |
|
|
2022
Q1 | $106K | Buy |
9,852
+8,252
| +516% | +$88.8K | ﹤0.01% | 2849 |
|
|
2021
Q4 | $26K | Hold |
1,600
| – | – | ﹤0.01% | 3190 |
|
|
2021
Q3 | $34K | Buy |
+1,600
| New | +$34K | ﹤0.01% | 3082 |
|